Literature DB >> 8919038

Expression of CD80 (B7/BB-1) and CD28 in human white blood cells treated with urocanic acid.

J K Laihia1, J Uksila, M Luhtala, C T Jansén.   

Abstract

Urocanic acid (UCA) is formed in the epidermis where it accumulates to be converted from trans- to cis-UCA by ultraviolet (UV) radiation. The two isomers modulate immune functions in several experimental systems. In particular, cis-UCA has been shown to induce antigen-specific immune tolerance, but the molecular mechanism of this effect is unknown. The present investigation was instituted to disclose any effect of UCA isomers on the cellular expression of the costimulatory antigens CD80 (B7/BB-1) and CD28. CD80 expression was efficiently induced in monocytic (CD14+) cells by human interferon-gamma, while CD28 levels on lymphocytes remained unchanged, as detected by flow cytometry. Neither UCA isomer showed any effect on the expression patterns of these costimulatory molecules. The results obtained suggest that the mode of action for epidermal UCA-induced tolerogenesis may not involve modulation of CD80 (B7/BB-1) or CD28 expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8919038     DOI: 10.1007/bf02505258

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  29 in total

1.  Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes.

Authors:  T Pedron; R Girard; R Chaby
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

2.  Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-gamma, or PMA: modulation of effects on CD11b and CD14 but not CD25 or CD54 induction.

Authors:  S Grey; H Hau; H H Salem; W W Hancock
Journal:  Transplant Proc       Date:  1993-10       Impact factor: 1.066

3.  Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules.

Authors:  J A Nunès; A Truneh; D Olive; D A Cantrell
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

4.  Effects of cis- and trans-urocanic acids on the secretion of interleukin-1 beta and tumour necrosis factor-alpha by human peripheral blood monocytes.

Authors:  J K Laihia; C T Jansén; J Uksila; J Punnonen; K Neuvonen; P Pasanen; P Ayräs
Journal:  Acta Derm Venereol       Date:  1994-07       Impact factor: 4.437

5.  Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.

Authors:  N K Damle; K Klussman; P S Linsley; A Aruffo
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

6.  Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes.

Authors:  F Willems; A Marchant; J P Delville; C Gérard; A Delvaux; T Velu; M de Boer; M Goldman
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

7.  Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation.

Authors:  M Grewe; K Gyufko; J Krutmann
Journal:  J Invest Dermatol       Date:  1995-01       Impact factor: 8.551

8.  Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.

Authors:  S T Grey; A Tsuchida; H Hau; C L Orthner; H H Salem; W W Hancock
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

9.  Heat-stable antigen is a costimulatory molecule for CD4 T cell growth.

Authors:  Y Liu; B Jones; A Aruffo; K M Sullivan; P S Linsley; C A Janeway
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

10.  B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.

Authors:  C Caux; B Vanbervliet; C Massacrier; M Azuma; K Okumura; L L Lanier; J Banchereau
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.